Jim Cramer Says Novo Nordisk A/S (NVO) Is ‘Down So Much’
We recently compiled a list of the Jim Cramer Discussed These 10 Stocks, AI Power Demand & Healthcare. In this article, we ...
Hosted on MSN24m
AKRO Stock Doubles in a Week as Lead Drug Meets Goal in MASH Study
Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week ...
BioPharma Dive5m
FDA clears use of Ozempic to protect kidney health
The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...
The Globe and Mail2m
Potential Revolution in Healthcare Brewing, Powered by AI Innovation
Issued on behalf of Avant Technologies Inc. Ainnova expects to submit its Pre-Sub application in the coming weeks and expects to meet with the FDA for its Pre-Sub meeting in late March/early April ...